Klaaborg Kaj-Erik, Egeblad Henrik, Jakobsen Carl-Johan, Terp Kim, Lindskov Christian, Andersen Henning Rud, Thuesen Leif
Department of Thoracic and Cardiovascular Surgery, Aarhus University Hospital, Skejby, Denmark.
Ann Thorac Surg. 2009 Jun;87(6):1943-6. doi: 10.1016/j.athoracsur.2008.11.034.
Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve (Edwards Lifesciences, Irvine, CA).
经导管经心尖或经股动脉主动脉瓣置换术已成为手术无法耐受的重度有症状瓣膜性主动脉狭窄患者的替代治疗方法。我们报告了一例对一名82岁女性患者严重狭窄的21毫米主动脉Mitroflow生物瓣膜（加拿大不列颠哥伦比亚省温哥华索林集团）进行经心尖治疗的病例，使用的是23毫米爱德华SAPIEN经导管心脏瓣膜（美国加利福尼亚州欧文市爱德华生命科学公司）。
